Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 8/2011

01.08.2011 | Symposium: Bone Quality: From Bench to Bedside

Bone Quality: From Bench to Bedside: Opening Editorial Comment

verfasst von: Adele L. Boskey, PhD, Eve Donnelly, PhD, J. Gregory Kinnett, MD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Excerpt

The term “bone quality” is frequently used by clinicians, basic scientists, and engineers. However, do they mean the same thing? In this symposium, we asked the authors what they meant by “bone quality,” and as the reader will discover, there are many aspects of bone quality that vary in importance and scope with the person providing the definition. In recent years, numerous reviews have explored and described bone quality (eg, [225, 29]) and some have discussed therapies for fragility fractures [13], but none has emphasized the transition from the bench to the bedside (and the operating room). In fact, the majority of these reviews of bone quality are either engineering or basic bone biology articles [36, 10, 11, 16], including imaging techniques [3, 8, 12, 17, 20, 25], or papers on how to treat osteoporosis [5, 7, 9, 15, 18, 19, 21, 23, 24]. Here too we review those topics, providing recent research data from leaders in the field. This symposium reviews and makes suggestions for appropriate management of individuals with impaired bone quality because the orthopaedic surgeon sees cases where the quality of the bone is abnormal, whether in patients with osteoporosis, osteopetrosis, cancer [14], or a metabolic problem, such as diabetes [22], kidney disease [29], or rheumatoid arthritis, and because little guidance is available on pre- and postsurgical management of these cases.
Literatur
1.
Zurück zum Zitat Anumula S, Magland J, Wehrli SL, Ong H, Song HK, Wehrli FW. Multi-modality study of the compositional and mechanical implications of hypomineralization in a rabbit model of osteomalacia. Bone. 2008;42:405–413.PubMedCrossRef Anumula S, Magland J, Wehrli SL, Ong H, Song HK, Wehrli FW. Multi-modality study of the compositional and mechanical implications of hypomineralization in a rabbit model of osteomalacia. Bone. 2008;42:405–413.PubMedCrossRef
2.
3.
Zurück zum Zitat Boskey AL. Assessment of bone mineral and matrix using backscatter electron imaging and FTIR imaging. Curr Osteoporos Rep. 2006;4:71–75.PubMedCrossRef Boskey AL. Assessment of bone mineral and matrix using backscatter electron imaging and FTIR imaging. Curr Osteoporos Rep. 2006;4:71–75.PubMedCrossRef
4.
Zurück zum Zitat Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14(Suppl 5):S118–S127.PubMedCrossRef Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14(Suppl 5):S118–S127.PubMedCrossRef
5.
Zurück zum Zitat Bouxsein ML. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin Cornerstone. 2003;5(Suppl 2):S13–S21.CrossRef Bouxsein ML. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin Cornerstone. 2003;5(Suppl 2):S13–S21.CrossRef
6.
Zurück zum Zitat Burr DB. Bone quality: understanding what matters. J Musculoskelet Neuronal Interact. 2004;4:184–186.PubMed Burr DB. Bone quality: understanding what matters. J Musculoskelet Neuronal Interact. 2004;4:184–186.PubMed
7.
Zurück zum Zitat Chesnut CH 3rd, Rosen CJ; Bone Quality Discussion Group. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res. 2001;16:2163–2172.PubMedCrossRef Chesnut CH 3rd, Rosen CJ; Bone Quality Discussion Group. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res. 2001;16:2163–2172.PubMedCrossRef
8.
Zurück zum Zitat Compston J. Bone quality: what is it and how is it measured? Arq Bras Endocrinol Metabol. 2006;50:579–585.PubMedCrossRef Compston J. Bone quality: what is it and how is it measured? Arq Bras Endocrinol Metabol. 2006;50:579–585.PubMedCrossRef
9.
Zurück zum Zitat Díez-Pérez A, González-Macías J. Inadequate responders to osteoporosis treatment: proposal for an operational definition. Osteoporos Int. 2008;19:1511–1516.PubMedCrossRef Díez-Pérez A, González-Macías J. Inadequate responders to osteoporosis treatment: proposal for an operational definition. Osteoporos Int. 2008;19:1511–1516.PubMedCrossRef
10.
Zurück zum Zitat Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. 2005;27:1–11.PubMedCrossRef Felsenberg D, Boonen S. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther. 2005;27:1–11.PubMedCrossRef
11.
Zurück zum Zitat Fyhrie DP. Summary—measuring ‘bone quality.’ J Musculoskelet Neuronal Interact. 2005;5:318–320.PubMed Fyhrie DP. Summary—measuring ‘bone quality.’ J Musculoskelet Neuronal Interact. 2005;5:318–320.PubMed
12.
Zurück zum Zitat Genant HK, Jiang Y. Advanced imaging assessment of bone quality. Ann N Y Acad Sci. 2006;1068:410–428.PubMedCrossRef Genant HK, Jiang Y. Advanced imaging assessment of bone quality. Ann N Y Acad Sci. 2006;1068:410–428.PubMedCrossRef
13.
Zurück zum Zitat Giannoudis P, Tzioupis C, Almalki T, Buckley R. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury. 2007;38(Suppl 1):S90–S99.PubMedCrossRef Giannoudis P, Tzioupis C, Almalki T, Buckley R. Fracture healing in osteoporotic fractures: is it really different? A basic science perspective. Injury. 2007;38(Suppl 1):S90–S99.PubMedCrossRef
14.
Zurück zum Zitat Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11:1121–1131.PubMedCrossRef Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11:1121–1131.PubMedCrossRef
15.
Zurück zum Zitat Heaney RP, Weaver CM. Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr. 2005;24:574S–5781S.PubMed Heaney RP, Weaver CM. Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr. 2005;24:574S–5781S.PubMed
16.
Zurück zum Zitat Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone. 2006;39:1173–1181.PubMedCrossRef Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality. Bone. 2006;39:1173–1181.PubMedCrossRef
17.
Zurück zum Zitat Judex S, Boyd S, Qin YX, Miller L, Müller R, Rubin C. Combining high-resolution micro-computed tomography with material composition to define the quality of bone tissue. Curr Osteoporos Rep. 2003;1:11–19.PubMedCrossRef Judex S, Boyd S, Qin YX, Miller L, Müller R, Rubin C. Combining high-resolution micro-computed tomography with material composition to define the quality of bone tissue. Curr Osteoporos Rep. 2003;1:11–19.PubMedCrossRef
18.
Zurück zum Zitat Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008;22:137–144.PubMedCrossRef Karsdal MA, Henriksen K, Arnold M, Christiansen C. Calcitonin: a drug of the past or for the future? Physiologic inhibition of bone resorption while sustaining osteoclast numbers improves bone quality. BioDrugs. 2008;22:137–144.PubMedCrossRef
19.
Zurück zum Zitat Karsdal MA, Qvist P, Christiansen C, Tankó LB. Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression? Drugs. 2006;66:1909–1918.PubMedCrossRef Karsdal MA, Qvist P, Christiansen C, Tankó LB. Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression? Drugs. 2006;66:1909–1918.PubMedCrossRef
20.
Zurück zum Zitat Kazakia GJ, Majumdar S. New imaging technologies in the diagnosis of osteoporosis. Rev Endocr Metab Disord. 2006;7:67–74.PubMedCrossRef Kazakia GJ, Majumdar S. New imaging technologies in the diagnosis of osteoporosis. Rev Endocr Metab Disord. 2006;7:67–74.PubMedCrossRef
21.
Zurück zum Zitat Kehoe T. Bone quality: a perspective from the Food and Drug Administration. Curr Osteoporos Rep. 2006;4:76–79.PubMedCrossRef Kehoe T. Bone quality: a perspective from the Food and Drug Administration. Curr Osteoporos Rep. 2006;4:76–79.PubMedCrossRef
22.
Zurück zum Zitat Khazai NB, Beck GR Jr, Umpierrez GE. Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009;16:435–445.PubMedCrossRef Khazai NB, Beck GR Jr, Umpierrez GE. Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009;16:435–445.PubMedCrossRef
23.
Zurück zum Zitat Kleerekoper M. Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporos Int. 2006;17:1707–1715.PubMedCrossRef Kleerekoper M. Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporos Int. 2006;17:1707–1715.PubMedCrossRef
24.
Zurück zum Zitat Licata AA. Clinical perspectives on bone quality in osteoporosis: effects of drug therapy. Drugs Aging. 2007;24:529–535.PubMedCrossRef Licata AA. Clinical perspectives on bone quality in osteoporosis: effects of drug therapy. Drugs Aging. 2007;24:529–535.PubMedCrossRef
25.
Zurück zum Zitat Müller R, van Lenthe GH. Trabecular bone failure at the microstructural level. Curr Osteoporos Rep. 2006;4:80–86.PubMedCrossRef Müller R, van Lenthe GH. Trabecular bone failure at the microstructural level. Curr Osteoporos Rep. 2006;4:80–86.PubMedCrossRef
26.
Zurück zum Zitat Watts NB. Bone quality: getting closer to a definition. J Bone Miner Res. 2002;17:1148–1150.PubMedCrossRef Watts NB. Bone quality: getting closer to a definition. J Bone Miner Res. 2002;17:1148–1150.PubMedCrossRef
27.
Zurück zum Zitat Wu Y, Ackerman JL, Chesler DA, Li J, Neer RM, Wang J, Glimcher MJ. Evaluation of bone mineral density using three-dimensional solid state phosphorus-31 NMR projection imaging. Calcif Tissue Int. 1998;62:512–518.PubMedCrossRef Wu Y, Ackerman JL, Chesler DA, Li J, Neer RM, Wang J, Glimcher MJ. Evaluation of bone mineral density using three-dimensional solid state phosphorus-31 NMR projection imaging. Calcif Tissue Int. 1998;62:512–518.PubMedCrossRef
28.
Zurück zum Zitat Wu Y, Hrovat MI, Ackerman JL, Reese TG, Cao H, Ecklund K, Glimcher MJ. Bone matrix imaged in vivo by water- and fat-suppressed proton projection MRI (WASPI) of animal and human subjects. J Magn Reson Imaging. 2010;31:954–963.PubMedCrossRef Wu Y, Hrovat MI, Ackerman JL, Reese TG, Cao H, Ecklund K, Glimcher MJ. Bone matrix imaged in vivo by water- and fat-suppressed proton projection MRI (WASPI) of animal and human subjects. J Magn Reson Imaging. 2010;31:954–963.PubMedCrossRef
29.
Zurück zum Zitat Zhang R, Alper B, Simon E, Florman S, Slakey D. Management of metabolic bone disease in kidney transplant recipients. Am J Med Sci. 2008;335:120–125.PubMedCrossRef Zhang R, Alper B, Simon E, Florman S, Slakey D. Management of metabolic bone disease in kidney transplant recipients. Am J Med Sci. 2008;335:120–125.PubMedCrossRef
Metadaten
Titel
Bone Quality: From Bench to Bedside: Opening Editorial Comment
verfasst von
Adele L. Boskey, PhD
Eve Donnelly, PhD
J. Gregory Kinnett, MD
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 8/2011
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-1785-2

Weitere Artikel der Ausgabe 8/2011

Clinical Orthopaedics and Related Research® 8/2011 Zur Ausgabe

Symposium: Bone Quality: From Bench to Bedside

Biographical Sketch: Fuller Albright, MD 1900–1969

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.